190 related articles for article (PubMed ID: 6718959)
1. [Trazodone in involuntary pathologic movements].
Rubino R; Provera P; Gilardengo P; Penza MT
Riv Neurol; 1984; 54(1):52-73. PubMed ID: 6718959
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutical approach to involuntary movements (author's transl)].
Allain H; Sabouraud O
Sem Hop; 1979 Feb 8-15; 55(5-6):262-4. PubMed ID: 219537
[TBL] [Abstract][Full Text] [Related]
3. [Cases of abnormal movements].
Singer B
Sem Hop; 1979 Jan 8-15; 55(1-2):83-4. PubMed ID: 34219
[TBL] [Abstract][Full Text] [Related]
4. [Abnormal involuntary movements in the elderly and their treatment (author's transl)].
Delwaide PJ; Desseilles M
Sem Hop; 1978 Nov 18-25; 54(41-42):1247-9. PubMed ID: 32624
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of abnormal movements of extrapyramidal origin with tiapride].
Ferrari G; Lovaste MG; Girardi P; Boninsegna C
Riv Neurol; 1981; 51(3):125-33. PubMed ID: 7256107
[TBL] [Abstract][Full Text] [Related]
6. [1st results of a study on the use of trazodone in the treatment of dyskinesia].
Papini M; Martinetti MG; Pasquinelli A; Milani Comparetti A; Gidoni EA; Fantini ML
Riv Neurobiol; 1981; 27(34):591-6. PubMed ID: 7052666
[No Abstract] [Full Text] [Related]
7. Involuntary movement disorders.
Still CN
Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089
[TBL] [Abstract][Full Text] [Related]
8. Movement disorders in the elderly.
Gilmore R
Geriatrics; 1984 Jun; 39(6):65-8, 72-6. PubMed ID: 6144615
[No Abstract] [Full Text] [Related]
9. Involuntary movements not due to parkinsonism.
Drug Ther Bull; 1974 Oct; 12(22):85-7. PubMed ID: 4156319
[No Abstract] [Full Text] [Related]
10. Clinical and electroencephalographical studies in patients with involuntary movements.
Kitagawa T
Yonago Acta Med; 1972 Nov; 15(3):225-33. PubMed ID: 5028949
[No Abstract] [Full Text] [Related]
11. Volitional control of involuntary movements.
Koller WC; Biary NM
Mov Disord; 1989; 4(2):153-6. PubMed ID: 2733707
[TBL] [Abstract][Full Text] [Related]
12. [Dyskinesia caused by L-DOPA].
Derkinderen P; Vidailhet M
Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S92-101. PubMed ID: 12690668
[TBL] [Abstract][Full Text] [Related]
13. Drug treatment of diseases characterized by abnormal movements.
Marsden CD
Proc R Soc Med; 1973 Sep; 66(9):871-3. PubMed ID: 4281483
[No Abstract] [Full Text] [Related]
14. Drug-induced motor complications in dopa-responsive dystonia: implications for the pathogenesis of dyskinesias and motor fluctuations.
de la Fuente-Fernández R
Clin Neuropharmacol; 1999; 22(4):216-9. PubMed ID: 10442251
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of dyskinetic syndromes].
Werdelin LM; Pakkenberg H
Nord Med; 1994; 109(12):341-4. PubMed ID: 7997372
[TBL] [Abstract][Full Text] [Related]
16. [The effect of thalamic stimulation on levodopa induced dyskinesias--evaluation of a new target: the center parafascicular median].
Caparros-Lefebvre D; Pollak P; Feltin MP; Blond S; Benabid AL
Rev Neurol (Paris); 1999 Sep; 155(8):543-50. PubMed ID: 10486844
[TBL] [Abstract][Full Text] [Related]
17. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
Zimmerman TR; Sage JI; Lang AE; Mark MH
Mov Disord; 1994 Mar; 9(2):173-7. PubMed ID: 8196678
[TBL] [Abstract][Full Text] [Related]
18. Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys.
Hadj Tahar A; Grégoire L; Darré A; Bélanger N; Meltzer L; Bédard PJ
Neurobiol Dis; 2004 Mar; 15(2):171-6. PubMed ID: 15006686
[TBL] [Abstract][Full Text] [Related]
19. An analysis of treatment options and outcome in patients with Parkinson's disease and severe dyskinesias.
Mark MH; Sage JI
Ann Clin Lab Sci; 1994; 24(1):12-21. PubMed ID: 8147565
[TBL] [Abstract][Full Text] [Related]
20. Involuntary movements and neurotransmitters.
Rondot P
Neuropediatrics; 1983 May; 14(2):59-65. PubMed ID: 6136007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
